A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Clinical trial NCT04228666 · WITHDRAWN

Trial details

NCT number: NCT04228666
Sponsor: Hope Biosciences LLC
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2020-03-01
Primary completion: 2022-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.